• Prévention

  • Ressources et infrastructures

A machine-learning approach to predicting smoking cessation treatment outcomes

Menée auprès de 90 fumeurs puis validée auprès de 71 fumeurs, cette étude analyse l'intérêt d'une approche d'apprentissage automatique utilisant les arbres de décision pour prédire les résultats des traitements destinés à accompagner la cessation tabagique

Aims : Most cigarette smokers want to quit smoking and more than half make an attempt every year, but less than 10% remain abstinent for at least 6 months. Evidence-based tobacco use treatment improves the likelihood of quitting, but more than two-thirds of individuals relapse when provided even the most robust treatments. Identifying for whom treatment is effective will improve the success of our treatments and perhaps identify strategies for improving current approaches.

Methods : Two cohorts (training: N=90, validation: N=71) of cigarette smokers enrolled in group CBT. Generalized estimating equations were used to identify baseline predictors of outcome, as defined by breath carbon monoxide and urine cotinine. Significant measures were entered as candidate variables to predict quit status. The resulting decision trees were used to predict cessation outcomes in a validation cohort.

Results : In the training cohort, the decision trees significantly improved on chance classification of smoking status following treatment and at 6-month follow-up. The first split of all decision trees, which was delay discounting, significantly improved on chance classification rates in both the training and validation cohort. Delay discounting emerged as the single best predictor of group CBT treatment response with an average baseline discount rate of ln(k) = -7.1 correctly predicting smoking status of 80% of participants at post-treatment and 81% of participants at follow-up.

Conclusions : The current study provides a first step towards personalized care for smoking cessation though future work is needed to identify individuals that are likely to be successful in treatments beyond group CBT.

Nicotine & Tobacco Research , résumé, 2017

Voir le bulletin